A detailed history of Tower Research Capital LLC (Trc) transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,532 shares of NAUT stock, worth $6,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,532
Previous 10,338 65.83%
Holding current value
$6,075
Previous $24,000 58.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.24 - $3.08 $15,245 - $20,962
-6,806 Reduced 65.83%
3,532 $10,000
Q2 2024

Aug 13, 2024

BUY
$2.22 - $3.0 $14,279 - $19,296
6,432 Added 164.67%
10,338 $24,000
Q1 2024

May 15, 2024

SELL
$2.41 - $3.18 $1,665 - $2,197
-691 Reduced 15.03%
3,906 $11,000
Q4 2023

Feb 13, 2024

BUY
$2.34 - $3.39 $208 - $301
89 Added 1.97%
4,597 $13,000
Q3 2023

Nov 14, 2023

BUY
$2.87 - $3.94 $6,575 - $9,026
2,291 Added 103.34%
4,508 $14,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.52 $5,560 - $11,372
-2,516 Reduced 53.16%
2,217 $8,000
Q1 2023

May 09, 2023

SELL
$1.67 - $2.77 $1,801 - $2,988
-1,079 Reduced 18.57%
4,733 $13,000
Q4 2022

Feb 10, 2023

SELL
$1.55 - $2.47 $655 - $1,044
-423 Reduced 6.78%
5,812 $10,000
Q3 2022

Nov 10, 2022

SELL
$1.96 - $3.13 $25,971 - $41,475
-13,251 Reduced 68.0%
6,235 $13,000
Q2 2022

Aug 15, 2022

BUY
$2.64 - $4.84 $45,054 - $82,599
17,066 Added 705.21%
19,486 $52,000
Q1 2022

May 12, 2022

SELL
$3.5 - $5.3 $525 - $795
-150 Reduced 5.84%
2,420 $11,000
Q4 2021

Feb 14, 2022

BUY
$4.45 - $6.21 $6,986 - $9,749
1,570 Added 157.0%
2,570 $14,000
Q3 2021

Nov 15, 2021

BUY
$6.14 - $10.1 $6,140 - $10,100
1,000 New
1,000 $6,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $214M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.